Timothy J. Bettington net worth and biography

Timothy Bettington Biography and Net Worth

Insider of Elanco Animal Health

Tim Bettington serves as Executive Vice President, Center of Strategic Growth.

With more than 25 years in the animal health industry, Tim joined Elanco in this role in March of 2023, after serving as Executive Vice President and President of U.S. Operations and Global Customer experience at Zoetis from 2020 to 2022. At Zoetis, he led the U.S. commercial operations supporting the livestock and companion animal portfolios. Prior to that, he served in roles with increasing responsibility over the course of his career, including as Global Head of Commercial Excellence from 2015 to 2016 and North American Region Head of Commercial Operations from 2017 to 2019, both at Boehringer Ingelheim Animal Health, working in both the livestock and companion animal sectors. He has worked in the U.S., Europe and Australia and developed a deep expertise in sales excellence, marketing, strategy and business integration.

Tim holds a bachelor’s degree in Agriculture from Western Sydney University and a master’s degree in Marketing Management from the Macquarie Graduate School of Management in Sydney, Australia.

What is Timothy J. Bettington's net worth?: The estimated net worth of Timothy J. Bettington is at least $3.26 million as of October 15th, 2026. Bettington owns 138,911 shares of Elanco Animal Health stock worth more than $3,264,270 as of October 19th. This net worth approximation does not reflect any other investments that Bettington may own. Learn More about Timothy J. Bettington's net worth.
How do I contact Timothy J. Bettington?: The corporate mailing address for Bettington and other Elanco Animal Health executives is 450 Elanco Circle, Indianapolis, IN, 46221. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Timothy J. Bettington's contact information.
Has Timothy J. Bettington been buying or selling shares of Elanco Animal Health?: During the last ninety days, Timothy J. Bettington has sold $100,050.00 in Elanco Animal Health stock. Most recently, Timothy J. Bettington sold 4,350 shares of the business's stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $23.00, for a transaction totalling $100,050.00. Following the completion of the sale, the insider now directly owns 138,911 shares of the company's stock, valued at $3,194,953. Learn More on Timothy J. Bettington's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes Timothy Bettington (Insider), John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), Paul Herendeen (Director), R. Hoover (Director), Lawrence Kurzius (Director), Rajeev Modi (Insider), Shiv O'Neill (Executive Vice President, General Counsel and Corporate Secretary), Jeffrey Simmons (President & CEO), Robert Vanhimbergen (CFO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 11 times. They purchased a total of 116,530 shares worth more than $2,610,798.08. During the last year, insiders at the sold shares 1 times. They sold a total of 4,350 shares worth more than $100,050.00. The most recent insider tranaction occured on October, 15th when insider Timothy J Bettington sold 4,350 shares worth more than $100,050.00. Insiders at Elanco Animal Health own 1.1% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 10/15/2026.

Timothy J. Bettington Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/15/2026	Sell	4,350	$23.00	$100,050.00	138,911

Timothy J. Bettington Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $23.50

$23.45

$23.96

50 Day Range

MA: $23.22

$21.78

$25.11

2 Week Range

Now: $23.50

$19.40

$27.98

Volume

2,900,342 shs

Average Volume

5,612,071 shs

Market Capitalization

$11.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7